Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
NCT ID:
NCT00446134
Pre Assignment Details:
Randomization was stratified by screening HCV RNA viral load less than or = to 2 or greater than (\>) 2 million copies/mL and body weight (BW) (less than or = 75 or \>75 kg). A cap of 70% was set for patients with BWs \>75 kg so that at least 30% of the patients in each group have BWs less than or = to 75 kg.
Recruitment Details:
Patients who met all entry criteria and signed an informed consent were randomized in a 1:1:1:1 ratio to one of the 4 arms by a central randomization schedule. A total of 51 clinical centers in the United States participated in the study. 278 patients were randomized; 275 patients who receive one dose of study drug were included in all analyses.
Study:
NCT00446134
Study Brief:
Results Section:
NCT00446134